Offer - Urjas Oil for just ₹ 1 X
Pio M 15 Tablet SR is a prescription medicine that is available as a Tablet. Other than this, Pio M 15 Tablet SR has some other therapeutic uses, which have been discussed ahead.
The right dosage of Pio M 15 Tablet SR depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Pio M 15 Tablet SR also has some side effects, the most common being Stomach Upset, Difficulty urinating, Muscle Ache. While these are the most often observed Pio M 15 Tablet SR side effects, there are can be others also. These have been listed below. Such side effects of Pio M 15 Tablet SR normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Pio M 15 Tablet SR has a Moderate effect for pregnant women and Moderate effect on lactating mothers. Warnings related to Pio M 15 Tablet SR's effects on the liver, heart and kidney, if any, have been listed below.
Pio M 15 Tablet SR is not recommended if you suffer from certain medical conditions as it can have adverse effects. Congestive Heart Failure (CHF), Anemia, Shock are examples of such conditions. Other conditions have been mentioned below in the Pio M 15 Tablet SR contraindications section.
Drug reaction of Pio M 15 Tablet SR with other medicines has been reported. See below for a complete list.
You should also be aware that Pio M 15 Tablet SR is safe while driving, and is addiction.
Pio M 15 Tablet SR is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Pio M 15 Tablet SR safe for pregnant women?
Pio M can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Pio M right away. Take your doctor's advice before taking it again.
Is the use of Pio M 15 Tablet SR safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Pio M. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Pio M 15 Tablet SR on the Kidneys?
Very few cases of side effects of Pio M on kidney have been reported.
What is the effect of Pio M 15 Tablet SR on the Liver?
You may experience side effects on your liver after taking Pio M. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Pio M 15 Tablet SR on the Heart?
Pio M may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
If you are suffering from any of the following diseases, you should not take Pio M 15 Tablet SR unless your doctor advises you to do so -
Is this Pio M 15 Tablet SR habit forming or addictive?
Forming a habit of Pio M 15 Tablet SR has not been reported.
Interaction between Food and Pio M 15 Tablet SR
There is no information on the effects of taking Pio M 15 Tablet SR with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Pio M 15 Tablet SR
Chances of side effects of drinking alcohol while taking Pio M 15 Tablet SR are low. If you feel any adverse effects, please seek medical advice as soon as possible.
Pio M can be taken forever, diabetes is a progressive disease it's possible that more medication and/or insulin may eventually need to be added to the regime.
No, you should not take alcohol with Pio M, because it can cause serious side effects which includes hypoglycemia (low blood sugar). The risk of hypoglycemia is higher when you're drinking and taking Pio M than if you're just taking Pio M. Some of the signs of hypoglycemia include dizziness, confusion, and drowsiness.
Lactic acidosis associated with Pio M treatment is a rare but fatal adverse effect. Lactic acidosis appears to result from biguanide interference causing an increase in production and decrease in clearance of lactate leading to higher cellular lactate levels. A decrease in pyruvate carboxylase activity, the rate-limiting enzyme in the formation of glucose from lactate, can also decrease hepatic metabolism of lactate. leading to increasing lactic acidosis. Signs and symptoms of Pio M induced lactic acidosis are nonspecific and include anorexia, nausea, vomiting, altered level of consciousness, hyperpnoea, abdominal pain, and thirst.
Pio M is not a known cause of alopecia (hair loss). However, the conditions treated by Pio M type 2 diabetes and PCOS, often list hair loss as a possible symptom.
Pio M is used with a proper diet and exercise program, to treat diabetes. It is also used with other medication to reduce the high blood sugar. It is used in a patient with type2 diabetes. It is also used in the treatment of polycystic ovarian syndrome (PCOS) and cancer.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actos (pioglitazone hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1032-1033